In vitro schedule-dependent interaction between paclitaxel and cisplatin in human carcinoma cell lines

Cancer Chemotherapy and Pharmacology

Volumn 37, Issue 6, 1996, Pages 525-530

  Kano, Yasuhiko ^a   Akutsu, Miyuki ^a   Tsunoda, Saburo ^a   Suzuki, Kenichi ^a   Yazawa, Yasuo ^a  

^a TOCHIGI CANCER CENTER   (Japan)

Author keywords

Cisplatin; Paclitaxel

Indexed keywords

CISPLATIN; PACLITAXEL;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER INHIBITION; CELL GROWTH; CELL STRAIN MCF 7; COLON CANCER; CONCENTRATION RESPONSE; CONTROLLED STUDY; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; OVARY CANCER; PRIORITY JOURNAL;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CELL DIVISION; CISPLATIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG INTERACTIONS; DRUG SYNERGISM; HUMANS; PACLITAXEL; TUMOR CELLS, CULTURED;

EID: 0029996423     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800050424     Document Type: Article

References (31)

1. Berenbaum MC (1988) What is synergy? Pharmacol Rev 41: 93
2. Bhalla KN, Kumar GN, Walle T, Stuart RK (1994) Phase I and pharmacokinetic trial of a 3 hour infusion of taxol, cisplatin plus 5-fluorouracil in advanced solid tumors (abstract). Proc Am Soc Clin Oncol 13: 165
3. Chaudhry V, Rowinsky EK, Sartorius SE, Donehower RC, Cornblath DR (1994) Peripheral neuropathy from taxol and cisplatin combination chemotherapy: clinical and electrophysiological studies. Ann Neurol 35: 304
4. Donehower RC, Rowinsky EK (1993) An overview of experience with taxol (paclitaxel) in the U.S.A. Cancer Treat Rev 19 (suppl C): 63
5. Donehower RC, Rowinsky EK, Grochow LB, Lomgnecker SM, Ettinger DS (1987) Phase I trial of taxol in patients with advanced cancer. Cancer Treat Rep 71: 1171
6. Gelmon KA, O'Reilly S, Plenderleith IH, Bryce C, Ragaz J, Coppin C, Campbell C, Healey D, Otto N (1994) Bi-weekly paclitaxel and cisplatin in the treatment of metastatic beast cancer (abstract). Proc Am Soc Clin Oncol 13: 71
7. Gercel-Taylor C, Taylor D, Owens K (1994) Effect of sequenting with taxol on the cisplatin sensitivity of ovarian cancer cell lines (abstract). Proc Am Assoc Cancer Res 35: 329
8. Grem JL, Tutsch KD, Simon KJ, Alberti DB, Willson JKV, Tormey DC, Swaminathan S, Trump DL (1987) Phase I study of taxol administered as a short i.v. infusion daily for 5 days. Cancer Treat Rep 71: 1179
9. Holmes FA, Walters RS, Theriaut RL, Forman AD, Newton LK, Raber MN, Buzder AU, Frye DK, Hortobagyi GN (1991) Phase II trial of taxol, an active drug in the treatment of metastatic breast cancer. J Natl Cancer Inst 83: 1797
10. Hoskins WJ, Brady MF, Kucera PR, Look KY, Partridge EE, Davidson M (1993) A phase III trial comparing cisplatin cytoxan and cisplatin/taxol in advanced ovarian cancer (abstract). Proc Am Soc Clin Oncol 12: 255
11. Jekunen A, Christen R, Shalinsky D, Howell SB (1994) Synergistic interaction between cisplatin and taxol in human ovarian carcinoma cells in vitro. Br J Cancer 69: 299
12. Kano Y, Ohnuma T, Okano T, Holland JF (1988) Effects of vincristine in combination with methotrexate and other antitumor agents in human acute lymphoblastic leukemia cells in culture. Cancer Res 48: 351
13. Kano Y, Sakamoto S, Kasahara T, Akutsu M, Inoue Y, Miura Y (1991) In vitro effects of amsacrine in combination with other anticancer agents. Leuk Res 15: 1059
14. Kano Y, Suzuki K, Akutsu M, Suda K, Inoue Y, Yoshida M, Sakamoto S, Miura Y (1992) Effects of CPT-11 in combination with other anticancer agents in culture. Int J Cancer 50: 604
15. Kern DH, Morgan CR (1993) Apparent in vitro antagonism between cisplatin and taxol (abstract). Proc Am Assoc Cancer Res 34: 300
16. Klastersky J, Sculier JP (1994) Dose-finding study paclitaxel (taxol) plus cisplatin in patients with non-small cell lung cancer. Semin Oncol 21 (Suppl 8): 39
17. Kohn E, Reed E, Link C, Christian M, Davis P, Sarosy G (1993) A pilot study of taxol, cisplatin, cyclophosphamide, and G-CSF in newly diagnosed stage III/IV ovarian cancer (abstract). Proc Am Soc Clin Oncol 12: 257
18. Kumar N (1981) Taxol-induced polymerization of purified tubulin. Mechanism of action. J Biol Chem 256: 10435
19. Liebmann J, Fisher J, Teage D, Cook JA (1994) Sequence dependence of paclitaxel combined with cisplatin or alkylators in human cancer cells. Oncol Res 6: 25
20. McGuire WP, Rowinsky EK, Rosenshein NB, Grumbine FC, Ettinger DS, Armstrong DK, Donehower RC (1989) Taxol: a unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms. Ann Intern Med 111: 273
21. McGuire WP, Hoskins WJ, Brady MF, Kucera PR, Look KY, Partridge EE, Davidson M (1993) A phase III trial comparing cisplatin cytoxan and cisplatin taxol in advanced ovarian cancer (abstract). Proc Am Soc Clin Oncol 12: 255
22. Murphy WK, Fossella FV, Winn RJ, Shin DM, Hynes E, Gross HM, Enrique D, Leimert J, Dhingra H, Raber MN, Krakoff IH, Hong WK (1993) Phase II study of taxol in untreated advanced non-small cell lung cancer. J Natl Cancer Inst 85: 384
23. Rowinsky EK, Gilbert MR, Mcguire WP, Noe DA, Grochow LB, Forostiere AA, Ettinger DS, Lubejko BG, Clark B, Sartorius SE, Cornblath DR, Hendricks CB, Donehower RC (1991) Sequences of taxol and cisplatin: a phase I and pharmacological study. J Clin Oncol 9: 1692
24. Rowinsky EK, Citardi MJ, Noe DA, Donehower RC (1993) Sequence-dependent cytotoxic effects due to combinations of cisplatin and the antimicrotubule agents taxol and vincristine. J Cancer Res Clin Oncol 119: 727
25. Schiff PB, Horwitz SB (1981) Taxol assembles tubulin in the absence of exogenous guanosine 5′-triphosphate or microtubule-associated proteins. Biochemistry 20: 3247
26. Schiff PB, Fant J, Horwitz SB (1979) Promotion of microtubule assembly in vitro by taxol. Nature 277: 665
27. Steel GG, Peckham MJ (1979) Exploitable mechanisms in combined radiotherapy-chemotherapy: the concept of additivity. Int J Radiat Oncol Biol Phys 5: 85
28. Untch M, Sevin BU, Perras JP, Angioli BA, Untch A, Hightower RD, Koechli O, Averette HE (1994) Evaluation of paclitaxel (taxol), cisplatin, and the combination of paclitaxel-cisplatin in ovarian cancer in vitro with the ATP cell viability. Gynecol Oncol 53: 44
29. Vanhoefer U, Harstrick A, Wilke H, Schleucher N, Walles H, Schroder J, Seeber S (1995) Schedule-dependent antagonism of paclitaxel and cisplatin in human gastric and ovarian carcinoma cell lines in vitro. Eur J Cancer 31: 92
30. Wani MC, Taylor HL, Wall ME, Coggen P, Mcphail AT (1971) Plant antitumor agents VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. J Am Chem Soc 93: 2325
31. Wiernik PH, Schwartz EL, Eizig A, Straumann JJ, Lipton RB, Dutcher JP (1987) Phase I trial of taxol given as a 24-hour infusion every 21 days: responses observed in metastatic melanoma. J Clin Oncol 5: 1232